Hematocrit Within Normal Range With Testosterone Gender-Affirming Therapy
MONDAY, Nov. 27, 2023 -- For people using testosterone as gender-affirming hormone therapy (GAHT), mean hematocrit varies from 41.84 to 45.68 percent, which is within the normal range, according to a study published online Nov. 27 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 27, 2023 Category: Pharmaceuticals Source Type: news
Cumulative incidence of all-cause knee injury, concussion, and stress fracture among transgender patients on gender-affirming hormone therapy: an exploratory retrospective cohort study - Miro EW, Taylor E, Curtin A, Newman MG, Ose D, Knox J.
Previous research has shown a discrepancy in incidences of knee injuries, stress fractures, and concussions between cisgender men and women. Little is known regarding the incidence of musculoskeletal injuries among patients on gender-affirming hormone ther... (Source: SafetyLit)
Source: SafetyLit - November 27, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
The effect of craniosacral therapy on blood levels of stress hormones in male firefighter cadets: a randomized clinical trial - W ójcik M, Bordoni B, Siatkowski I, Żekanowska E.
(1) Background: Fire department cadets preparing to become firefighters and paramedics experience high levels of stress when participating in incidents like traffic accidents and fires. Stress adversely affects health, and coping with it proves difficult. ... (Source: SafetyLit)
Source: SafetyLit - November 27, 2023 Category: International Medicine & Public Health Tags: Age: Young Adults Source Type: news
Global Synthetic Hormones Market Analysis and Forecast, 2023-2033: Focus on Product Type, Application, Route of Administration, End User, Region, and Competitive Landscape
DUBLIN, Nov. 24, 2023 /PRNewswire/ -- The "Global Synthetic Hormones Market: Focus on Product Type, Application, Route of Administration, End User, Region, and Competitive Landscape - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 25, 2023 Category: Pharmaceuticals Tags: MRR Source Type: news
Feeling full? Researchers pinpoint neurons that prevent eating too much, too
As millions in the United States settle down to Thanksgiving dinner this week, few will be pondering a major question in neuroscience: Why, when so much of life across the animal kingdom revolves around finding and consuming food, do we ever
stop
eating?
Scientists have identified brain regions and even specific cells involved in terminating meals. But exactly how this process is coordinated remains murky. Now, using brain recordings from mice tucking into food, researchers have for the first time identified how specific neurons in a region called the caudal nucleus of the solitary tract (cNTS) switch on du...
Source: ScienceNOW - November 22, 2023 Category: Science Source Type: news
Choosing the Right Approach to Cancer and Menopause Symptoms Choosing the Right Approach to Cancer and Menopause Symptoms
Hormone replacement therapy may be considered to lessen these symptoms, but only in certain conditions, said a gynecologist.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 21, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
FDA Approved A New Weight Loss Drug Zepbound. Here ’s What To Know And Expect
Zepbound works by mimicking two naturally occurring hormones in the body, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 21, 2023 Category: Pharmaceuticals Authors: Omer Awan, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news
Hunger hormones can impact decision-making: Study
The blood-brain barrier is known to strictly restrict many substances in the blood from reaching the brain. The study findings are published in the journal, Neuron Researchers put mice in an arena that had some food, and looked at how the mice acted when they were hungry or full. (Source: The Economic Times)
Source: The Economic Times - November 19, 2023 Category: Consumer Health News Source Type: news
Contraceptives May Slow Brain Development And Increase Risk-Taking Behavior In Teens, Study Suggests
Authored by Megan Redshaw via The Epoch Times (emphasis ours), Synthetic hormones used for birth control may slow brain maturation and disrupt the development of an area of the brain responsible…#meganredshaw #epochtimes #synthetic #adolescents #ohiostateuniversity #kathrynlenz #ohiostate (Source: Reuters: Health)
Source: Reuters: Health - November 18, 2023 Category: Consumer Health News Source Type: news
FDA Approves Truqap (capivasertib) plus Faslodex for Patients with Advanced HR-Positive Breast Cancer
17 November 2023 -- AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the US for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 17, 2023 Category: Drugs & Pharmacology Source Type: news
First AKT Inhibitor Approved for Advanced Breast Cancer
(MedPage Today) -- The FDA approved the first-in-class AKT inhibitor capivasertib (Truqap), in combination with fulvestrant, for locally advanced/metastatic hormone receptor (HR)-positive/HER2-negative breast cancer and at least one specific genetic... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 17, 2023 Category: American Health Source Type: news
Transgender minors sue University of Missouri for refusing puberty blockers, hormones
The federal lawsuit alleges that barring gender-affirming care to minors is discriminatory. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 17, 2023 Category: Pharmaceuticals Source Type: news
Improving Shared Decision-Making in HER2-Low Breast Cancer Improving Shared Decision-Making in HER2-Low Breast Cancer
A breast cancer specialist and a patient with metastatic HER2-low disease share perspectives on optimizing doctor-patient communication at key changes in treatment, such as starting hormonal therapy.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 16, 2023 Category: Consumer Health News Tags: None Care Cues Source Type: news
Inito, a startup that helps women quickly track fertility hormones at home, raises $6M
Inito, a YC alum that helps women track fertility hormones quickly at home, has raised $6 million in Series A funding led by Fireside Ventures. The startup’s fertility monitor and kit is designed to give users easy-to-read fertility diagnostic results directly on their phone in just 10 minutes.…#firesideventures #bengaluru #aayushrai #ctovarunav #siemens #av #estrogen #lh #fsh #progesterone (Source: Reuters: Health)
Source: Reuters: Health - November 15, 2023 Category: Consumer Health News Source Type: news
Novel MASH Drug Reduces Liver Fat in Mid-Stage Trial
(MedPage Today) -- BOSTON -- Treatment with an investigational thyroid hormone receptor-beta (THR-β) agonist significantly reduced liver fat content in patients with metabolic dysfunction-associated steatohepatitis (MASH), a placebo-controlled... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 15, 2023 Category: Gastroenterology Source Type: news
